We did it!! I am really honoured to lead this important FIH study! A novel transurethral robotic system that can make ERBT much easier, and hopefully we can generalize the technique to every urologist globally. A better surgery will lead to better outcomes!! 🌎 #UroSoMe

Ab#5001 ASCO #ASCO25 by #CharlesParker👉bit.ly/4k8kTGb👉Multimodal AI model (MMAI) in pts w/ high-risk nmPC #prostatecancer 👉MMAI can identify pts benefit from the addition of ARPI 👇 Nick James also on @Prof-Nick-James.bsky.social AttardLab OncoAlert UroToday.com PCF Science

This is how long it takes to get to the organ of interest. Don’t blink, you may miss it. #SPrevolution

Expression of Platelet-Derived Growth Factor Alpha and Beta Receptors in Primary Tumor Cells of Patients with Renal Cell Carcinoma Maria Volkova et al. #plateletderivedgrowthfactor #renalcellcarcinoma Article Link : urologyresearchandpractice.org/en/expression-…

I feel truly honoured to lead this important first-in-human trial using the Virtuoso Robotic System for something that is very close to my heart - En bloc resection of bladder tumour. #UroSoMe (1/n) youtu.be/gTUv-cq-ICI?si…

📺 Star TV’deydik ! Erkek infertilitesine dair bilinmeyenleri, doğru bilinen yanlışları ve güncel tedavi yöntemlerini “Özgür Koldaş ile Sağlık Gündemi”nde konuştuk. #Erkekİnfertilitesi #SağlıkGündemi #varikosel #üroloji #androloji #StarTV youtu.be/a3Y8hx3P08U?si…

Reporting the Impact of Pelvicalyceal System (PCS) Anatomy on Clinical Outcomes in Retrograde Intrarenal Surgery (#RIRS) Studies: Can We Do Better? – Methodological Review from the Section of EAU Endourology Ali Talyshinskii et al. Prof Bhaskar Somani Link : urologyresearchandpractice.org/en/reporting-t…

A Comparison of Postoperative Urological Infection Rates Between Supine and Prone Positions During #PercutaneousNephrolithotomy Nattanachoti Batratanakij et al. #PCNL #proneposition #supineposition #urologicalinfection Article Link: urologyresearchandpractice.org/en/a-compariso…

📢Not all CIS are created equal Our latest BJU International study shows that 𝗺𝘂𝗹𝘁𝗶𝗳𝗼𝗰𝗮𝗹 𝗖𝗜𝗦: - Associated w/⬆️progression risk (esp. in T1) -⬆️risk despite adequate BCG - Emphasizes why separate tumour specimens matter for accurate tumour mapping doi.org/10.1111/bju.16…

Altered Endothelin Receptor Expression in Idiopathic Male Infertility: A Potential Therapeutic Target Richard Weiten et al. #endothelinreceptors #maleinfertility #spermatozoa #oligoasthenoteratozoospermia Article Link : urologyresearchandpractice.org/en/sexual-medi…

Targeting Prostate Cancer Cells by an Isopeptidase Inhibitor NSC632839 Ummuhan Demir et al. #prostatecancer #NSC632839 #SENP2 Article Link: urologyresearchandpractice.org/en/targeting-p…

#Tebipenem pivoxil hydrobromide (HBr) is a late-stage development asset developed in collaboration with GSK. Tebipenem HBr is being developed to treat cUTIs, including pyelonephritis. The new drug has the feature of being one of the first #carbapenem antibiotic that can be taken

Uncovering New Horizons: Update to Quadruple-D Score to Predict Stone-Free Rate with Advanced Non- invasive Lithotripsy Technology Aaron Tigor Sihombing et al. #nomogram #piezoelectric #shockwavelithotripsy #stonefreerate Article Link : urologyresearchandpractice.org/en/uncovering-…

ORIC® Pharmaceuticals Announces Potentially Best-In-Class Preliminary Efficacy and Safety Data from Ongoing Phase 1b Trial of ORIC-944 in Combination with AR Inhibitors for the Treatment of Patients with mCRPC | ORIC Pharmaceuticals, Inc. investors.oricpharma.com/news-releases/…

☑️Inspiring? YES! ☑️Broadening horizons? YES! ☑️Insightful for the value of multidisciplinary work? YES! #ASCO25 sessions include patients' perspective along with clinical🩺 and laboratory-focused🔬 talks! "If you want to go fast, go alone. If you want to go far, go together!"

#VIOLET Study of Terbium-161 (Tb-161) Beta/Auger therapy ASCO #ASCO25 First prospective trial of Terbium-161 in any tumour type 🟣 30 patient trial in prostate cancer. No dose limiting toxicities at highest level of radioactivity (7.4 GBq) 🟣 Very few side effects: 1 grade 3